Islet Endothelial Activation and Oxidative Stress Gene Expression Is Reduced by IL-1Ra Treatment in the Type 2 Diabetic GK Rat

Inflammation followed by fibrosis is a component of islet dysfunction in both rodent and human type 2 diabetes. Because islet inflammation may originate from endothelial cells, we assessed the expression of selected genes involved in endothelial cell activation in islets from a spontaneous model of type 2 diabetes, the Goto-Kakizaki (GK) rat. We also examined islet endotheliuml/oxidative stress (OS)/inflammation-related gene expression, islet vascularization and fibrosis after treatment with the interleukin-1 (IL-1) receptor antagonist (IL-1Ra)

Ressenti et vécu des patients qui tendent vers l institutionnalisation suite à un évènement médical aigu (Etude qualitative auprès de onze patients à l aide d entretiens semi-dirigés)

BESANCON-BU Médecine pharmacie (250562102) / SudocSudocFranceF

Back to basics: optimization of DNA and RNA transfer in muscle cells using recent transfection reagents

AbstractPublication Experimental Cell Research Optimization of DNA and RNA transfer in muscle cells using recent transfection reagent

Proposed model illustrating the islet endothelial dysfunction and oxidative stress surrounding β cells in GK rats.

<p>Elevated glucose, FFA and possibly cytokines induce endothelial activation at the islet level by eliciting reactive oxygen species (ROS) production and cytokine/chemokine release by endothelial cells and vascular smooth muscle cells. Once released, chemokines (CXCL1, CCL2, CCL3) attract/retain immune cells (monocytes, neutrophils), which further induce ROS and cytokine production around β cells. In addition, cytokines as well as metabolic factors (high glucose and FFA) may act directly on β cells to increase intracellular cytokines and ROS production with consecutive antioxidant defense response. Antagonizing IL-1 by IL-1Ra may inhibit endothelial activation/dysfunction and subsequent immune cells attraction/activation. IL-1Ra may also blunt IL-1 signaling in β cells and subsequent ROS production and antioxidant defense response. CXCL1 (GRO1/KC, rodent equivalent of IL-8), CCL2 (MCP-1); CCL3 (MIP-1α); FFA (free fatty acids); IL-1β, interleukin-1β; IL-1Ra, interleukin-1 receptor antagonist; IL-6, interleukin-6; TNF-α, tumor necrosis factor-α.</p

Metabolic data for 10-week-old control Wistar and diabetic GK male rats.

<p>Glucose, insulin, leptin, lipids, cytokine and chemokine levels were determined in serum. Alpha-tocopherol and homocysteine levels, and paraoxonase-1 (PON-1) activity were determined in plasma. Glutathione redox state (% of reduced glutathione (GSH)) and GSH content (Eq GSH) were determined in red blood cells (RBC). Glucose, insulin, leptin: n = 7 per group; lipids: n = 9 per group; cytokines/chemokines: n = 7 per group; α-tocopherol, glutathione redox state and GSH content (n = 7–13 per group) and homocysteine and PON-1: n = 7–8 per group. All parameters were assayed under fed conditions. FFA (free fatty acids); HDL: high density lipoproteins; GRO1/KC/CXCL1: rodent equivalent of IL-8; MCP-1/CCL2: monocyte/macrophage chemoattractant protein; MIP-1α/CCL3: macrophage inflammatory protein-1α; IL-6, interleukin-6. ^*p<0.05 versus age-matched Wistar group, as analyzed by Student's <i>t</i>-test.</p

Expression of genes encoding factors involved in endothelium activation and inflammation in GK islets.

<p>Total RNA was extracted from freshly isolated islets of 2.5-month-old male Wistar and GK rats and quantitative RT-PCR was performed for the indicated genes and normalized to a housekeeping gene (rpL19 or Ef1a). Data are means±SEM of 5–6 different islet isolations per group except for caspase-1 and epoxide hydrolase-2 (n = 3).^*p<0.05 using Student's <i>t</i>-test.</p

IL-1Ra treatment improves vascularization and reduces fibrosis in GK islets.

<p>Immunohistochemistry was performed for von Willebrand factor (VWF) (A) and fibronectin (B) in pancreas of young adult untreated Wistar and GK rats, and of s.c. saline- or IL-1Ra-treated-GK rats. The border of each islet is defined by the dashed line. As shown in panel A, VWF-labeled islets from untreated GK rats are extremely heterogeneous in terms of vascularization and extent of fibrosis, when compared to Wistar controls. In saline- and IL-1Ra-treated GK rats, immunolabeled islet area for VWF or fibronectin was quantified for each islet and expressed as to the corresponding islet surface (n = 3 GK rats for both treatment groups, n = 25–40 islets). Islets analyzed for quantification showed unchanged islet area between treatment groups. ^*p<0.05 using Student's <i>t</i>-test.</p

IL-1Ra treatment reduces the expression of most of the selected genes for endothelial activation, oxidative stress, myeloid cells, and fibrosis in GK islets.

<p>Pancreatic islets were isolated from GK rats following 1-month-treatment with IL-1Ra by s.c. injections (GK saline n = 6, GK IL-1Ra (100 mg/kg/day), n = 5). For each animal, total RNA was extracted from isolated islets and quantitative RT-PCR was performed for the indicated genes, and expressed relative to GK saline. ^*p<0.05 using Student's <i>t</i>-test.</p

Primer oligonucleotide sequences of selected genes.

<p>Primer oligonucleotide sequences of selected genes.</p